Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Interviews
Podcasts
Videos & Webinars
News
Infographics
Society updates
Submit A Paper
Retatrutide Cuts Sleep Apnea Events in Phase III Trials
October 2026
Retatrutide significantly reduced nighttime breathing disruptions in adults with obstructive sleep apnea across two randomized clinical trials.
Read more
24 Oct 2026
Retatrutide Cuts Sleep Apnea Events in Phase III Trials
Retatrutide significantly reduced nighttime breathing disruptions in adults with obstructive sleep apnea across two randomized clinical trials.
22 Oct 2026
Shared Metabolic Pathway Drives Cystic Fibrosis Lung Disease
A shared metabolic pathway may drive airway damage and persistent bacterial infections in people with cystic fibrosis.
22 Oct 2026
Computational Lung Models Show Promise for Personalized ARDS Care
Computational lung models accurately predicted key ventilation parameters in patients with acute respiratory distress syndrome.
20 Oct 2026
RSV Linked to Severe Complications After Lung Transplant
RSV in lung transplant recipients was associated with respiratory failure, declining lung function, and mortality in hospitalized patients.
17 Oct 2026
RSV Vaccination Associated With Survival Benefit in Heart Failure
RSV vaccination was associated with lower mortality and fewer ICU admissions in older adults with heart failure.
15 Oct 2026
Virtual Reality Rehabilitation Improves Early ARDS Recovery
Virtual reality rehabilitation improved cognition, quality of life, and anxiety during early recovery after acute respiratory distress syndrome.
13 Oct 2026
AI Struggles With Severe Asthma Biologic Selection
AI in severe asthma showed poor agreement with multidisciplinary teams when selecting biologic therapy for uncontrolled disease.
10 Oct 2026
4-Week Pediatric Home Ventilation Pathway Appears Safe
A standardized pediatric home mechanical ventilation pathway supported safe discharge without increasing early hospital revisits.
Loading posts...
1
2
3
…
43
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View